ANUHPHR
NSEAnuh Pharma Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹79.59
3.31 (4.34%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹798 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
18.6
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹67+18.8%
52W High₹114.84-30.7%
Current Price
₹79.59
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹63.67
Upper Circuit₹95.51
Reference Price
₹79.59
Investment Checklist
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹74.81
Double Top on 1D (BREAKOUT CONFIRMED) — target ₹87.66
Unusual volume detected (5.7x average) — institutional activity likely
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
EMA(20) Crossover: Price crossed above EMA(20): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
44%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bearish MA stack (20<50<200)
EMA20
77.36
EMA50
77.92
EMA200
82.31
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows5
Lower Highs4
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹79.70
₹82.57
₹83.87
₹84.95
₹86.53
Support (Below)
₹77.55
₹74.00
₹72.50
₹69.27
₹67.00
Volume Analysis
TrendINCREASING
Change+39.70%
Unusual Volume
Yes (5.69x avg)
Stop Loss Levels
Fixed Risk
1% Risk₹78.79
3% Risk₹77.20
5% Risk₹75.61
7% Risk (Custom)
₹74.02Technical Levels
1x ATR (Volatility)₹76.58
2x ATR (Swing)₹73.57
3x ATR (Trend)₹70.56
Immediate Support₹77.55
Moving Averages
EMA 9 (Short-term)₹76.99
EMA 20 (Medium-term)₹77.36
EMA 50 (Trend)₹77.92
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹198.1 Cr | ₹186.5 Cr | ₹185.9 Cr | ₹197.2 Cr |
| Net Profit | ₹12.5 Cr | ₹8.3 Cr | ₹7.6 Cr | ₹13.5 Cr |
| EPS | — | ₹0.83 | ₹0.76 | ₹1.34 |
| Operating Profit | ₹20.1 Cr | ₹13.7 Cr | ₹12.9 Cr | ₹20.9 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 14 Aug 2025 | Dividend - Rs 1.50 Per Share | DIVIDEND |
| 15 Jul 2025 | Bonus 1:1 | BONUS |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ANUHPHR
View AllNEWS
positive
Business Standard - Markets 23d ago
Anuh Pharma standalone net profit declines 6.26% in the March 2026 quarter
Sales rise 2.01% to Rs 202.12 crore
ANUHPHRHealthcare
positive
Business Standard - Markets 39d ago
Anuh Pharma up 7% on receiving WHO prequalification for anti-malarial API
The buying on the counter came after the company received World Health Organization (WHO) prequalification approval for Amodiaquine Hydrochloride USP
ANUHPHRMEDANTAHealthcare